These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 36510584)

  • 81. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma.
    Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L
    J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284
    [TBL] [Abstract][Full Text] [Related]  

  • 82. CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma.
    Lin X; Zhao X; Chen Y; Yang R; Dai Z; Li W; Lin C; Cao W
    Int J Immunopathol Pharmacol; 2024; 38():3946320241227312. PubMed ID: 38252495
    [No Abstract]   [Full Text] [Related]  

  • 83. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
    Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
    Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Identification of immune-related genes contributing to head and neck squamous cell carcinoma development using weighted gene co-expression network analysis.
    Guo Q; Lu T; Xu H; Luo Q; Liu Z; Jiang S; Pan J; Lin S; Lin M; Guo F
    Cancer Rep (Hoboken); 2023 May; 6(5):e1808. PubMed ID: 37092360
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Expression of
    Zhang P; Zhao Y; Xia X; Mei S; Huang Y; Zhu Y; Yu S; Chen X
    Oncoimmunology; 2023; 12(1):2203073. PubMed ID: 37089448
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
    Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
    Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
    Li Z; Shen L; Li Y; Shen L; Li N
    Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A senescence-related lncRNA signature predicts prognosis and reflects immune landscape in HNSCC.
    Chen L; Lin J; Wen Y; Lan B; Xiong J; Fu Y; Chen Y; Chen CB
    Oral Oncol; 2024 Feb; 149():106659. PubMed ID: 38134702
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
    Ma B; Li H; Qiao J; Meng T; Yu R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comprehensive analysis of the prognosis and biological significance of ROR
    Zheng J; Tang H; Yang Y; Yang K
    Environ Toxicol; 2024 Feb; 39(2):487-508. PubMed ID: 37278231
    [TBL] [Abstract][Full Text] [Related]  

  • 93. FRZB: a potential prognostic marker for head and neck squamous cell carcinoma.
    Li Y; Gu F; Huang X; Huang W; Xiang J; Yue J; Wang Y; Chen R
    Braz J Med Biol Res; 2024; 57():e13368. PubMed ID: 38775547
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Prognostic Role of Cuproptosis in Head and Neck Squamous Cell Carcinoma Patients: A Comprehensive Analysis.
    Ding Q; Chen X; Hong W; Wang L; Liu W; Cai S; Chen X; Lu J; Qiu S
    Dis Markers; 2022; 2022():9996946. PubMed ID: 36092958
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 96. FAT1 as a tumor mutation burden specific gene affects the immunotherapy effect in head and neck squamous cell cancer.
    Cao H; Lan T; Kuang S; Wang L; Li J; Li Q; Li Y; Xu Q; Chen Q; Ren S; Lan C; Ouyang N; Liao J; Huang Y; Li J
    Drug Resist Updat; 2024 Sep; 76():101095. PubMed ID: 38986165
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 98. TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis.
    He R; Zhang X; Wu Y; Weng Z; Li L
    Cancer Med; 2023 Dec; 12(24):22354-22369. PubMed ID: 37990988
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A prognostic model based on Scissor
    Tian G; Zhang J; Bao Y; Li Q; Hou J
    Cell Signal; 2024 Feb; 114():110984. PubMed ID: 38029947
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.